BioLineRx
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $4,943 | $5,393 | $6,855 | $6,855 |
Gross Profit | 4,121 | 4,496 | 5,400 | 5,400 |
EBITDA | -3,357 | 3,296 | 878 | |
EBIT | -4,197 | 2,569 | 232 | |
Net Income | -5,822 | 484 | -696 | -696 |
Net Change In Cash | 4,943 | 5,393 | 6,855 | 6,855 |
Free Cash Flow | -9,825 | -11,356 | -14,141 | -14,141 |
Cash | 8,836 | 9,623 | 5,990 | 5,990 |
Basic Shares | 79,965 | 79,838 | 1,086,589 | 72,439 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $4,800 | $0 | $0 | $0 |
Gross Profit | 1,108 | -654 | -702 | -934 |
EBITDA | -57,061 | -28,503 | -25,346 | -21,993 |
EBIT | -58,445 | -29,157 | -26,048 | -22,927 |
Net Income | -60,614 | -18,872 | -28,144 | -30,932 |
Net Change In Cash | 4,800 | 0 | 0 | 0 |
Free Cash Flow | -22,905 | -26,556 | -23,670 | -23,206 |
Cash | 4,255 | 10,587 | 12,990 | 16,831 |
Basic Shares | 64,224 | 51,597 | 44,195 | 16,856 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.07 |
2024-06-30 | $0.006 |
2024-03-31 | -$0.01 |
2023-12-31 | -$0.15 |
